Kelly Financial Services’s Biogen BIIB Stock Holding History

Kelly Financial Services’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-564	Closed	-$131K	–	181
2024 Q2	$131K	Hold	564	–	–	0.05%	127
2024 Q1	$122K	Hold	564	–	–	0.05%	136
2023 Q4	$146K	Hold	564	–	–	0.06%	113
2023 Q3	$145K	Hold	564	–	–	0.07%	99
2023 Q2	$161K	Hold	564	–	–	0.08%	94
2023 Q1	$157K	Hold	564	–	–	0.08%	90
2022 Q4	$156K	Hold	564	–	–	0.08%	92
2022 Q3	$151K	Hold	564	–	–	0.09%	86
2022 Q2	$115K	Hold	564	–	–	0.06%	108
2022 Q1	$119K	Hold	564	–	–	0.05%	115
2021 Q4	$135K	Hold	564	–	–	0.06%	104
2021 Q3	$160K	Hold	564	–	–	0.09%	77
2021 Q2	$195K	Sell	564 -4,200	-88%	-$1.27M	0.11%	63
2021 Q1	$1.33M	Buy	4,764 +282	+6%	+$76.1K	0.83%	12
2020 Q4	$1.1M	Hold	4,482	–	–	0.75%	11
2020 Q3	$1.27M	Hold	4,482	–	–	0.91%	11
2020 Q2	$1.2M	Buy	4,482 +11	+0.2%	+$3.31K	0.93%	11
2020 Q1	$1.41M	Hold	4,471	–	–	1.74%	8
2019 Q4	$1.33M	Buy	4,471 +38	+0.9%	+$10.5K	1.02%	8
2019 Q3	$1.03M	Buy	4,433 +5	+0.1%	+$1.16K	0.94%	7
2019 Q2	$1.04M	Hold	4,428	–	–	0.94%	7
2019 Q1	$1.05M	Buy	+4,428	New	+$1.39M	1.16%	7

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Kelly Financial Services's BIIB Position: Q3 2024 in Review

Kelly Financial Services sold out of Biogen (BIIB) in Q3 2024, closing a stake of 564 shares — an estimated $131K sold.

Kelly Financial Services first reported a position in BIIB in Q1 2019 and held it in 22 quarters. The position peaked at $1.41M in Q1 2020. 917 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

Kelly Financial Services reported no remaining Biogen position as of Q3 2024 after selling out during the quarter.
Kelly Financial Services sold 564 Biogen shares in Q3 2024, an estimated $131K.
Kelly Financial Services first reported a position in Biogen in Q1 2019 and held it in 22 quarters.
Kelly Financial Services's Biogen position peaked at $1.41M in Q1 2020.
917 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on Kelly Financial Services's 13F filing for Q3 2024, filed 9 Oct 2024.